Neuros Biotechnology

United Kingdom
West Meon, England, United Kingdom

Company profile

Neuros Biotechnology company profile

Neuros Biotechnology, pioneering a groundbreaking approach to combating Alzheimer's disease (AD) through innovative neurogenic therapies, aims to treat AD holistically, addressing every aspect of lifestyle-related disease modification, combined with harnessing the potent capabilities of NB-Px, a human-derived mixed biologic with unique neuro-regenerative properties.

Business identity

Phone number
(408) 348-5056
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$25,000
Last funding
Pre Seed / $25,000 / 2025-04-14
Last equity funding
Pre Seed / $25,000
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Simon Selwood

Lead investors

TEDCO

Investors

TEDCO